469 lines
98 KiB
Text
469 lines
98 KiB
Text
<!DOCTYPE html>
|
|
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" class="no-js no-jr">
|
|
<head>
|
|
<!-- For pinger, set start time and add meta elements. -->
|
|
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
|
|
|
<!-- Logger begin -->
|
|
<meta name="ncbi_db" content="books">
|
|
<meta name="ncbi_pdid" content="book-part">
|
|
<meta name="ncbi_acc" content="NBK1105">
|
|
<meta name="ncbi_domain" content="gene">
|
|
<meta name="ncbi_report" content="reader">
|
|
<meta name="ncbi_type" content="fulltext">
|
|
<meta name="ncbi_objectid" content="">
|
|
<meta name="ncbi_pcid" content="/NBK1105/?report=reader">
|
|
<meta name="ncbi_pagename" content="Spinocerebellar Ataxia with Axonal Neuropathy Type 1 - GeneReviews® - NCBI Bookshelf">
|
|
<meta name="ncbi_bookparttype" content="chapter">
|
|
<meta name="ncbi_app" content="bookshelf">
|
|
<!-- Logger end -->
|
|
|
|
<!--component id="Page" label="meta"/-->
|
|
<script type="text/javascript" src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.boots.min.js"> </script><title>Spinocerebellar Ataxia with Axonal Neuropathy Type 1 - GeneReviews® - NCBI Bookshelf</title>
|
|
<meta charset="utf-8">
|
|
<meta name="apple-mobile-web-app-capable" content="no">
|
|
<meta name="viewport" content="initial-scale=1,minimum-scale=1,maximum-scale=1,user-scalable=no">
|
|
<meta name="jr-col-layout" content="auto">
|
|
<meta name="jr-prev-unit" content="/books/n/gene/sca38/?report=reader">
|
|
<meta name="jr-next-unit" content="/books/n/gene/spondylocostal-d/?report=reader">
|
|
<meta name="bk-toc-url" content="/books/n/gene/?report=toc">
|
|
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE">
|
|
<meta name="citation_inbook_title" content="GeneReviews® [Internet]">
|
|
<meta name="citation_title" content="Spinocerebellar Ataxia with Axonal Neuropathy Type 1">
|
|
<meta name="citation_publisher" content="University of Washington, Seattle">
|
|
<meta name="citation_date" content="2022/06/30">
|
|
<meta name="citation_author" content="Mustafa AM Salih">
|
|
<meta name="citation_author" content="Hiroshi Takashima">
|
|
<meta name="citation_author" content="Cornelius F Boerkoel">
|
|
<meta name="citation_pmid" content="20301284">
|
|
<meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1105/">
|
|
<meta name="citation_keywords" content="SCAN1, TDP1-Related Spinocerebellar Ataxia with Axonal Neuropathy">
|
|
<meta name="citation_keywords" content="SCAN1">
|
|
<meta name="citation_keywords" content="TDP1-Related Spinocerebellar Ataxia with Axonal Neuropathy">
|
|
<meta name="citation_keywords" content="Tyrosyl-DNA phosphodiesterase 1">
|
|
<meta name="citation_keywords" content="TDP1">
|
|
<meta name="citation_keywords" content="Spinocerebellar Ataxia with Axonal Neuropathy Type 1">
|
|
<link rel="schema.DC" href="http://purl.org/DC/elements/1.0/">
|
|
<meta name="DC.Title" content="Spinocerebellar Ataxia with Axonal Neuropathy Type 1">
|
|
<meta name="DC.Type" content="Text">
|
|
<meta name="DC.Publisher" content="University of Washington, Seattle">
|
|
<meta name="DC.Contributor" content="Mustafa AM Salih">
|
|
<meta name="DC.Contributor" content="Hiroshi Takashima">
|
|
<meta name="DC.Contributor" content="Cornelius F Boerkoel">
|
|
<meta name="DC.Date" content="2022/06/30">
|
|
<meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1105/">
|
|
<meta name="description" content="Spinocerebellar ataxia with axonal neuropathy type 1 (SCAN1) is characterized by late-childhood-onset slowly progressive cerebellar ataxia and distal sensorimotor axonal neuropathy. Gaze nystagmus and dysarthria usually develop after the onset of ataxic gait. As the disease advances, pain and touch sensation in the hands and feet become impaired; vibration sense is lost in hands and lower thighs. Individuals with advanced disease develop a steppage gait and pes cavus and eventually become wheelchair dependent. Cognitive dysfunction – present in some – manifests as mild intellectual disability and poor executive function. To date only seven affected individuals have been described from three apparently unrelated consanguineous families (one from Saudi Arabia and two from Oman); therefore, it is likely that the full phenotypic spectrum of this disorder is not yet known.">
|
|
<meta name="og:title" content="Spinocerebellar Ataxia with Axonal Neuropathy Type 1">
|
|
<meta name="og:type" content="book">
|
|
<meta name="og:description" content="Spinocerebellar ataxia with axonal neuropathy type 1 (SCAN1) is characterized by late-childhood-onset slowly progressive cerebellar ataxia and distal sensorimotor axonal neuropathy. Gaze nystagmus and dysarthria usually develop after the onset of ataxic gait. As the disease advances, pain and touch sensation in the hands and feet become impaired; vibration sense is lost in hands and lower thighs. Individuals with advanced disease develop a steppage gait and pes cavus and eventually become wheelchair dependent. Cognitive dysfunction – present in some – manifests as mild intellectual disability and poor executive function. To date only seven affected individuals have been described from three apparently unrelated consanguineous families (one from Saudi Arabia and two from Oman); therefore, it is likely that the full phenotypic spectrum of this disorder is not yet known.">
|
|
<meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1105/">
|
|
<meta name="og:site_name" content="NCBI Bookshelf">
|
|
<meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png">
|
|
<meta name="twitter:card" content="summary">
|
|
<meta name="twitter:site" content="@ncbibooks">
|
|
<meta name="bk-non-canon-loc" content="/books/n/gene/scan1/?report=reader">
|
|
<link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1105/">
|
|
<link href="https://fonts.googleapis.com/css?family=Archivo+Narrow:400,700,400italic,700italic&subset=latin" rel="stylesheet" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/libs.min.css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/jr.min.css">
|
|
<meta name="format-detection" content="telephone=no">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css//books_print.min.css" type="text/css" media="print">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_reader.min.css" type="text/css">
|
|
<style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} .body-content h2, .body-content .h2 {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list .graphic {display:inline-block !important} .temp-labeled-list img{width:100%}</style>
|
|
|
|
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico">
|
|
<meta name="ncbi_phid" content="CE8DEEFF7C8A85D1000000000090007B.m_5">
|
|
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3849091.css"></head>
|
|
<body>
|
|
<!-- Book content! -->
|
|
|
|
|
|
<div id="jr" data-jr-path="/corehtml/pmc/jatsreader/ptpmc_3.22/"><div class="jr-unsupported"><table class="modal"><tr><td><span class="attn inline-block"></span><br />Your browser does not support the NLM PubReader view.<br />Go to <a href="/pmc/about/pr-browsers/">this page</a> to see a list of supported browsers<br />or return to the <br /><a href="/books/NBK1105/?report=classic">regular view</a>.</td></tr></table></div><div id="jr-ui" class="hidden"><nav id="jr-head"><div class="flexh tb"><div id="jr-tb1"><a id="jr-links-sw" class="hidden" title="Links"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" x="0px" y="0px" viewBox="0 0 70.6 85.3" style="enable-background:new 0 0 70.6 85.3;vertical-align:middle" xml:space="preserve" width="24" height="24">
|
|
<style type="text/css">.st0{fill:#939598;}</style>
|
|
<g>
|
|
<path class="st0" d="M36,0C12.8,2.2-22.4,14.6,19.6,32.5C40.7,41.4-30.6,14,35.9,9.8"></path>
|
|
<path class="st0" d="M34.5,85.3c23.2-2.2,58.4-14.6,16.4-32.5c-21.1-8.9,50.2,18.5-16.3,22.7"></path>
|
|
<path class="st0" d="M34.7,37.1c66.5-4.2-4.8-31.6,16.3-22.7c42.1,17.9,6.9,30.3-16.4,32.5h1.7c-66.2,4.4,4.8,31.6-16.3,22.7 c-42.1-17.9-6.9-30.3,16.4-32.5"></path>
|
|
</g>
|
|
</svg> Books</a></div><div class="jr-rhead f1 flexh"><div class="head"><a href="/books/n/gene/sca38/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="body"><div class="t">Spinocerebellar Ataxia with Axonal Neuropathy Type 1</div><div class="j">GeneReviews® [Internet]</div></div><div class="tail"><a href="/books/n/gene/spondylocostal-d/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></div><div id="jr-tb2"><a id="jr-bkhelp-sw" class="btn wsprkl hidden" title="Help with NLM PubReader">?</a><a id="jr-help-sw" class="btn wsprkl hidden" title="Settings and typography in NLM PubReader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512" preserveAspectRatio="none"><path d="M462,283.742v-55.485l-29.981-10.662c-11.431-4.065-20.628-12.794-25.274-24.001 c-0.002-0.004-0.004-0.009-0.006-0.013c-4.659-11.235-4.333-23.918,0.889-34.903l13.653-28.724l-39.234-39.234l-28.72,13.652 c-10.979,5.219-23.68,5.546-34.908,0.889c-0.005-0.002-0.01-0.003-0.014-0.005c-11.215-4.65-19.933-13.834-24-25.273L283.741,50 h-55.484l-10.662,29.981c-4.065,11.431-12.794,20.627-24.001,25.274c-0.005,0.002-0.009,0.004-0.014,0.005 c-11.235,4.66-23.919,4.333-34.905-0.889l-28.723-13.653l-39.234,39.234l13.653,28.721c5.219,10.979,5.545,23.681,0.889,34.91 c-0.002,0.004-0.004,0.009-0.006,0.013c-4.649,11.214-13.834,19.931-25.271,23.998L50,228.257v55.485l29.98,10.661 c11.431,4.065,20.627,12.794,25.274,24c0.002,0.005,0.003,0.01,0.005,0.014c4.66,11.236,4.334,23.921-0.888,34.906l-13.654,28.723 l39.234,39.234l28.721-13.652c10.979-5.219,23.681-5.546,34.909-0.889c0.005,0.002,0.01,0.004,0.014,0.006 c11.214,4.649,19.93,13.833,23.998,25.271L228.257,462h55.484l10.595-29.79c4.103-11.538,12.908-20.824,24.216-25.525 c0.005-0.002,0.009-0.004,0.014-0.006c11.127-4.628,23.694-4.311,34.578,0.863l28.902,13.738l39.234-39.234l-13.66-28.737 c-5.214-10.969-5.539-23.659-0.886-34.877c0.002-0.005,0.004-0.009,0.006-0.014c4.654-11.225,13.848-19.949,25.297-24.021 L462,283.742z M256,331.546c-41.724,0-75.548-33.823-75.548-75.546s33.824-75.547,75.548-75.547 c41.723,0,75.546,33.824,75.546,75.547S297.723,331.546,256,331.546z"></path></svg></a><a id="jr-fip-sw" class="btn wsprkl hidden" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-rtoc-sw" class="btn wsprkl hidden" title="Table of Contents"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,20h10v8H20V20zM36,20h44v8H36V20zM20,37.33h10v8H20V37.33zM36,37.33h44v8H36V37.33zM20,54.66h10v8H20V54.66zM36,54.66h44v8H36V54.66zM20,72h10v8 H20V72zM36,72h44v8H36V72z"></path></svg></a></div></div></nav><nav id="jr-dash" class="noselect"><nav id="jr-dash" class="noselect"><div id="jr-pi" class="hidden"><a id="jr-pi-prev" class="hidden" title="Previous page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a><div class="pginfo">Page <i class="jr-pg-pn">0</i> of <i class="jr-pg-lp">0</i></div><a id="jr-pi-next" class="hidden" title="Next page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div><div id="jr-is-tb"><a id="jr-is-sw" class="btn wsprkl hidden" title="Switch between Figures/Tables strip and Progress bar"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><rect x="10" y="40" width="20" height="20"></rect><rect x="40" y="40" width="20" height="20"></rect><rect x="70" y="40" width="20" height="20"></rect></svg></a></div><nav id="jr-istrip" class="istrip hidden"><a id="jr-is-prev" href="#" class="hidden" title="Previous"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M80,40 60,65 80,90 70,90 50,65 70,40z M50,40 30,65 50,90 40,90 20,65 40,40z"></path><text x="35" y="25" textLength="60" style="font-size:25px">Prev</text></svg></a><a id="jr-is-next" href="#" class="hidden" title="Next"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,40 40,65 20,90 30,90 50,65 30,40z M50,40 70,65 50,90 60,90 80,65 60,40z"></path><text x="15" y="25" textLength="60" style="font-size:25px">Next</text></svg></a></nav><nav id="jr-progress"></nav></nav></nav><aside id="jr-links-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">NCBI Bookshelf</div></div><div class="cnt lol f1"><a href="/books/">Home</a><a href="/books/browse/">Browse All Titles</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://www.facebook.com/sharer/sharer.php?u=https://www.ncbi.nlm.nih.gov/books/NBK1105/"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24" preserveAspectRatio="none"><g><path d="M 17.996,32L 12,32 L 12,16 l-4,0 l0-5.514 l 4-0.002l-0.006-3.248C 11.993,2.737, 13.213,0, 18.512,0l 4.412,0 l0,5.515 l-2.757,0 c-2.063,0-2.163,0.77-2.163,2.209l-0.008,2.76l 4.959,0 l-0.585,5.514L 18,16L 17.996,32z"></path></g></svg> Share on Facebook</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://twitter.com/intent/tweet?url=https://www.ncbi.nlm.nih.gov/books/NBK1105/&text=Spinocerebellar%20Ataxia%20with%20Axonal%20Neuropathy%20Type%201"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24"><g><path d="M 32,6.076c-1.177,0.522-2.443,0.875-3.771,1.034c 1.355-0.813, 2.396-2.099, 2.887-3.632 c-1.269,0.752-2.674,1.299-4.169,1.593c-1.198-1.276-2.904-2.073-4.792-2.073c-3.626,0-6.565,2.939-6.565,6.565 c0,0.515, 0.058,1.016, 0.17,1.496c-5.456-0.274-10.294-2.888-13.532-6.86c-0.565,0.97-0.889,2.097-0.889,3.301 c0,2.278, 1.159,4.287, 2.921,5.465c-1.076-0.034-2.088-0.329-2.974-0.821c-0.001,0.027-0.001,0.055-0.001,0.083 c0,3.181, 2.263,5.834, 5.266,6.438c-0.551,0.15-1.131,0.23-1.73,0.23c-0.423,0-0.834-0.041-1.235-0.118 c 0.836,2.608, 3.26,4.506, 6.133,4.559c-2.247,1.761-5.078,2.81-8.154,2.81c-0.53,0-1.052-0.031-1.566-0.092 c 2.905,1.863, 6.356,2.95, 10.064,2.95c 12.076,0, 18.679-10.004, 18.679-18.68c0-0.285-0.006-0.568-0.019-0.849 C 30.007,8.548, 31.12,7.392, 32,6.076z"></path></g></svg> Share on Twitter</a></div></aside><aside id="jr-rtoc-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Table of Content</div></div><div class="cnt lol f1"><a href="/books/n/gene/?report=reader">Title Information</a><a href="/books/n/gene/toc/?report=reader">Table of Contents Page</a></div></aside><aside id="jr-help-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Settings</div></div><div class="cnt f1"><div id="jr-typo-p" class="typo"><div><a class="sf btn wsprkl">A-</a><a class="lf btn wsprkl">A+</a></div><div><a class="bcol-auto btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 200 100" preserveAspectRatio="none"><text x="10" y="70" style="font-size:60px;font-family: Trebuchet MS, ArialMT, Arial, sans-serif" textLength="180">AUTO</text></svg></a><a class="bcol-1 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M15,25 85,25zM15,40 85,40zM15,55 85,55zM15,70 85,70z"></path></svg></a><a class="bcol-2 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M5,25 45,25z M55,25 95,25zM5,40 45,40z M55,40 95,40zM5,55 45,55z M55,55 95,55zM5,70 45,70z M55,70 95,70z"></path></svg></a></div></div><div class="lol"><a class="" href="/books/NBK1105/?report=classic">Switch to classic view</a><a href="/books/NBK1105/pdf/Bookshelf_NBK1105.pdf">PDF (453K)</a><a href="/books/NBK1105/?report=printable">Print View</a></div></div></aside><aside id="jr-bkhelp-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Help</div></div><div class="cnt f1 lol"><a id="jr-helpobj-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/help.xml" href="">Help</a><a href="mailto:info@ncbi.nlm.nih.gov?subject=PubReader%20feedback%20%2F%20NBK1105%20%2F%20sid%3ACE8B5AF87C7FFCB1_0191SID%20%2F%20phid%3ACE8DEEFF7C8A85D1000000000090007B.4">Send us feedback</a><a id="jr-about-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/about.xml" href="">About PubReader</a></div></aside><aside id="jr-objectbox" class="thidden hidden"><div class="jr-objectbox-close wsprkl">✘</div><div class="jr-objectbox-inner cnt"><div class="jr-objectbox-drawer"></div></div></aside><nav id="jr-pm-left" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Previous Page</text></svg></nav><nav id="jr-pm-right" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Next Page</text></svg></nav><nav id="jr-fip" class="hidden"><nav id="jr-fip-term-p"><input type="search" placeholder="search this page" id="jr-fip-term" autocorrect="off" autocomplete="off" /><a id="jr-fip-mg" class="wsprkl btn" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-fip-done" class="wsprkl btn" title="Dismiss find">✘</a></nav><nav id="jr-fip-info-p"><a id="jr-fip-prev" class="wsprkl btn" title="Jump to previuos match">◀</a><button id="jr-fip-matches">no matches yet</button><a id="jr-fip-next" class="wsprkl btn" title="Jump to next match">▶</a></nav></nav></div><div id="jr-epub-interstitial" class="hidden"></div><div id="jr-content"><article data-type="main"><div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><div class="fm-sec"><h1 id="_NBK1105_"><span class="title" itemprop="name">Spinocerebellar Ataxia with Axonal Neuropathy Type 1</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: SCAN1, <i>TDP1</i>-Related Spinocerebellar Ataxia with Axonal Neuropathy</div><p class="contribs">Salih MAM, Takashima H, Boerkoel CF.</p><p class="fm-aai"><a href="#_NBK1105_pubdet_">Publication Details</a></p><p><em>Estimated reading time: 15 minutes</em></p></div></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="scan1.Summary" itemprop="description"><h2 id="_scan1_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Spinocerebellar ataxia with axonal neuropathy type 1 (SCAN1) is characterized by late-childhood-onset slowly progressive cerebellar ataxia and distal sensorimotor axonal neuropathy. Gaze nystagmus and dysarthria usually develop after the onset of ataxic gait. As the disease advances, pain and touch sensation in the hands and feet become impaired; vibration sense is lost in hands and lower thighs. Individuals with advanced disease develop a steppage gait and pes cavus and eventually become wheelchair dependent. Cognitive dysfunction – present in some – manifests as mild intellectual disability and poor executive function. To date only seven affected individuals have been described from three apparently unrelated consanguineous families (one from Saudi Arabia and two from Oman); therefore, it is likely that the full phenotypic spectrum of this disorder is not yet known.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of SCAN1 is established in a proband with suggestive findings and biallelic pathogenic (or likely pathogenic) variants in <i>TDP1</i> identified by molecular genetic testing.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Supportive care provided by specialists in neurology, rehabilitation medicine, occupational therapy, physical therapy, speech-language pathology, and clinical genetics.</p><p><i>Surveillance</i>: Routine follow up as determined by treating specialists to monitor the response to supportive care and to assess for changes in existing manifestations and/or emergence of new manifestations.</p><p><i>Agents/circumstances to avoid</i>: Because <i>TDP1</i> codes for a DNA repair enzyme, genotoxic anti-cancer drugs such as camptothecins (e.g., irinotecan and topotecan) and bleomycin are likely to be extremely harmful and possibly fatal; exposure to radiation is also likely to be extremely harmful and possibly fatal.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>SCAN1 is inherited in an autosomal recessive manner. If both parents are known to be heterozygous for a <i>TDP1</i> pathogenic variant, each sib of an affected individual has at conception a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of inheriting neither of the familial pathogenic variants. Once the <i>TDP1</i> pathogenic variants have been identified in an affected family member, carrier testing for at-risk relatives and prenatal and preimplantation genetic testing are possible.</p></div></div><div id="scan1.Diagnosis"><h2 id="_scan1_Diagnosis_">Diagnosis</h2><p>No consensus clinical diagnostic criteria for spinocerebellar ataxia with axonal neuropathy type 1 (SCAN1) have been published.</p><div id="scan1.Suggestive_Findings"><h3>Suggestive Findings</h3><p>SCAN1 is suspected in individuals with the following clinical findings, electrophysiologic studies, laboratory findings, brain imaging, and family history [<a class="bibr" href="#scan1.REF.takashima.2002.267" rid="scan1.REF.takashima.2002.267">Takashima et al 2002</a>, <a class="bibr" href="#scan1.REF.scott.2019.139" rid="scan1.REF.scott.2019.139">Scott et al 2019</a>].</p><p>
|
|
<b>Clinical findings</b>
|
|
</p><ul><li class="half_rhythm"><div>Slowly progressive disorder beginning in late childhood to early adulthood (ages 13-27 years)</div></li><li class="half_rhythm"><div>Cerebellar ataxia manifesting initially as gait ataxia and subsequently as dysarthria</div></li><li class="half_rhythm"><div>Distal sensorimotor neuropathy manifesting initially as areflexia and subsequently as weakness and loss of sensation</div></li><li class="half_rhythm"><div>Cognitive dysfunction in some, manifesting as mild intellectual disability and poor executive function</div></li><li class="half_rhythm"><div>Absence of:</div><ul><li class="half_rhythm"><div>Oculomotor apraxia</div></li><li class="half_rhythm"><div>Extraneurologic findings</div></li></ul></li></ul><p><b>Nerve conduction studies / electromyogram findings</b> are consistent with distal axonal neuropathy.</p><p><b>Laboratory findings.</b> Mildly decreased serum albumin, hypercholesterolemia, and elevated serum alpha fetoprotein support the diagnosis of SCAN1.</p><p><b>Brain MRI</b> shows cerebellar atrophy especially of the vermis.</p><p><b>Family history</b> is consistent with autosomal recessive inheritance (e.g., affected sibs and/or parental consanguinity). Absence of a known family history does not preclude the diagnosis.</p></div><div id="scan1.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of SCAN1 <b>is established</b> in a proband with suggestive findings and biallelic pathogenic (or likely pathogenic) variants in <i>TDP1</i> identified by molecular genetic testing (see <a href="/books/NBK1105/table/scan1.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-ob="figobscan1Tmoleculargenetictestingusedi">Table 1</a>).</p><p>Note: (1) Per ACMG/AMP variant interpretation guidelines, the terms "pathogenic variant" and "likely pathogenic variant" are synonymous in a clinical setting, meaning that both are considered diagnostic and can be used for clinical decision making [<a class="bibr" href="#scan1.REF.richards.2015.405" rid="scan1.REF.richards.2015.405">Richards et al 2015</a>]. Reference to "pathogenic variants" in this <i>GeneReview</i> is understood to include likely pathogenic variants. (2) Identification of biallelic <i>TDP1</i> variants of uncertain significance (or identification of one known <i>TDP1</i> pathogenic variant and one <i>TDP1</i> variant of uncertain significance) does not establish or rule out the diagnosis.</p><p>Because the phenotype of SCAN1 is indistinguishable from many other inherited disorders with ataxia, recommended molecular genetic testing approaches include use of a <b>multigene panel</b> or <b>comprehensive genomic testing</b>.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>An ataxia</b>
|
|
<b>multigene panel</b> that includes <i>TDP1</i> and other genes of interest (see <a href="#scan1.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition while limiting identification of variants of uncertain significance and pathogenic variants in genes that do not explain the underlying phenotype. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused exome analysis that includes genes specified by the clinician. (4) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/?report=reader#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/?report=reader#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Comprehensive genomic testing</b> does not require the clinician to determine which genes are likely involved. <b>Exome sequencing</b> is most commonly used; <b>genome sequencing</b> is also possible.</div><div class="half_rhythm">For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/?report=reader#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/?report=reader#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figscan1Tmoleculargenetictestingusedi"><a href="/books/NBK1105/table/scan1.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" title="Table 1. " class="img_link icnblk_img" rid-ob="figobscan1Tmoleculargenetictestingusedi"><img class="small-thumb" src="/corehtml/pmc/css/bookshelf/2.26/img/table-icon.gif" alt="Table Icon" /></a><div class="icnblk_cntnt"><h4 id="scan1.T.molecular_genetic_testing_used_i"><a href="/books/NBK1105/table/scan1.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-ob="figobscan1Tmoleculargenetictestingusedi">Table 1. </a></h4><p class="float-caption no_bottom_margin">Molecular Genetic Testing Used in Spinocerebellar Ataxia with Axonal Neuropathy Type 1 </p></div></div></div></div><div id="scan1.Clinical_Characteristics"><h2 id="_scan1_Clinical_Characteristics_">Clinical Characteristics</h2><div id="scan1.Clinical_Description"><h3>Clinical Description</h3><p>Spinocerebellar ataxia with axonal neuropathy type 1 (SCAN1) is characterized by progressive ataxia, cerebellar atrophy, and distal sensorimotor axonal neuropathy based on findings in three persons in a consanguineous family from Saudi Arabia [<a class="bibr" href="#scan1.REF.takashima.2002.267" rid="scan1.REF.takashima.2002.267">Takashima et al 2002</a>] and four affected individuals from two apparently unrelated consanguineous families from Oman [<a class="bibr" href="#scan1.REF.scott.2019.139" rid="scan1.REF.scott.2019.139">Scott et al 2019</a>]. The following description of the phenotypic features associated with this condition is based on these two reports.</p><p><b>Cerebellar ataxia.</b> Ataxic gait appears in the second decade of life between ages 13 and 15 years. The ataxia progresses slowly, initially manifesting as mild incoordination of the upper limbs and lower limbs and then progressing to inability to walk.</p><p>Horizontal gaze-evoked nystagmus and mild dysarthria usually develop after the onset of ataxic gait.</p><p><b>Neuropathy.</b> Weakness initially develops in the hands and feet with preserved strength of the more proximal upper and lower leg muscles. Progression of the weakness is accompanied by atrophy of the muscles of the fingers and feet, fasciculations, and mild weakness.</p><p>Deep tendon reflexes are lost in the third decade of life.</p><p>Sensory function is initially preserved. As the disease advances, pain, cold, and touch sensations become severely impaired in the hands and lower thigh. Vibration sense disappears in the hands and legs.</p><p>In the advanced stages of the disease, affected persons develop a steppage gait and pes cavus.</p><p>Dysphagia develops with progression of the cerebellar ataxia.</p><p><b>Cognitive function.</b> Mildly impaired intellectual capacity has been observed [<a class="bibr" href="#scan1.REF.scott.2019.139" rid="scan1.REF.scott.2019.139">Scott et al 2019</a>].</p><p><b>Other.</b> One individual developed adult-onset epilepsy (grand mal) [<a class="bibr" href="#scan1.REF.takashima.2002.267" rid="scan1.REF.takashima.2002.267">Takashima et al 2002</a>].</p></div><div id="scan1.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No genotype-phenotype correlations are known as the data available are too limited [<a class="bibr" href="#scan1.REF.takashima.2002.267" rid="scan1.REF.takashima.2002.267">Takashima et al 2002</a>, <a class="bibr" href="#scan1.REF.scott.2019.139" rid="scan1.REF.scott.2019.139">Scott et al 2019</a>].</p></div><div id="scan1.Nomenclature"><h3>Nomenclature</h3><p>SCAN1 may also be referred to as "<i>TDP1</i>-related spinocerebellar ataxia with axonal neuropathy" based on the dyadic naming approach proposed by <a class="bibr" href="#scan1.REF.biesecker.2021.8" rid="scan1.REF.biesecker.2021.8">Biesecker et al [2021]</a> to delineate mendelian genetic disorders.</p></div><div id="scan1.Prevalence"><h3>Prevalence</h3><p>Spinocerebellar ataxia with axonal neuropathy type 1 (SCAN1) is very rare.</p><p>To date, one extended family from Saudi Arabia with nine affected individuals [<a class="bibr" href="#scan1.REF.takashima.2002.267" rid="scan1.REF.takashima.2002.267">Takashima et al 2002</a>] and two apparently unrelated families from Oman [<a class="bibr" href="#scan1.REF.scott.2019.139" rid="scan1.REF.scott.2019.139">Scott et al 2019</a>] have been reported with the same variant, <a href="/books/NBK1105/table/scan1.T.notable_tdp1_pathogenic_variants/?report=objectonly" target="object" rid-ob="figobscan1Tnotabletdp1pathogenicvariants">c.1478A>G; p.His493Arg</a>. A shared homozygous haplotype identified in the probands from the Omani families suggests a founder haplotype [<a class="bibr" href="#scan1.REF.scott.2019.139" rid="scan1.REF.scott.2019.139">Scott et al 2019</a>]. Although haplotype studies were not performed on the Saudi Arabian family, it may share ancestral origin with the Omani individuals.</p></div></div><div id="scan1.Genetically_Related_Allelic_Disord"><h2 id="_scan1_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with germline pathogenic variants in <i>TDP1</i>.</p></div><div id="scan1.Differential_Diagnosis"><h2 id="_scan1_Differential_Diagnosis_">Differential Diagnosis</h2><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figscan1Tgenesofinterestinthediffere"><a href="/books/NBK1105/table/scan1.T.genes_of_interest_in_the_differe/?report=objectonly" target="object" title="Table 2. " class="img_link icnblk_img" rid-ob="figobscan1Tgenesofinterestinthediffere"><img class="small-thumb" src="/corehtml/pmc/css/bookshelf/2.26/img/table-icon.gif" alt="Table Icon" /></a><div class="icnblk_cntnt"><h4 id="scan1.T.genes_of_interest_in_the_differe"><a href="/books/NBK1105/table/scan1.T.genes_of_interest_in_the_differe/?report=objectonly" target="object" rid-ob="figobscan1Tgenesofinterestinthediffere">Table 2. </a></h4><p class="float-caption no_bottom_margin">Genes of Interest in the Differential Diagnosis of Spinocerebellar Ataxia with Axonal Neuropathy Type 1 </p></div></div></div><div id="scan1.Management"><h2 id="_scan1_Management_">Management</h2><p>No clinical practice guidelines for spinocerebellar ataxia with axonal neuropathy type 1 (SCAN1) have been published.</p><div id="scan1.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with SCAN1, the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Complete neurologic examination including use of the Scale for the Assessment and Rating of Ataxia (SARA) and assessment of muscle strength, reflexes, and sensation</div></li><li class="half_rhythm"><div>Assessment by specialists in rehabilitation medicine, occupational therapy, and physical therapy regarding gross motor skills, fine motor skills, and need for adaptive equipment such as prostheses, walking aids, and/or wheelchairs</div></li><li class="half_rhythm"><div>Assessment by a speech-language pathologist for evidence of dysarthria and need for ongoing speech-language therapy</div></li><li class="half_rhythm"><div>Consultation with a medical geneticist, certified genetic counselor, or certified advanced genetic nurse to inform affected individuals and their families about the nature, mode of inheritance, and implications of SCAN1 in order to facilitate medical and personal decision making</div></li></ul><p>To support the family of an individual diagnosed with SCAN1, review of the following options is recommended:</p><ul><li class="half_rhythm"><div>Use of community or online resources (e.g., <a href="https://www.p2pusa.org/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Parent to Parent</a>)</div></li><li class="half_rhythm"><div>Social work involvement for parental support</div></li><li class="half_rhythm"><div>Home nursing referral (if needed)</div></li><li class="half_rhythm"><div>Ethics consultation (clinical ethics services) to assess health care decisions in the context of the best interest of the child and the values and preferences of the family</div></li></ul></div><div id="scan1.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>There is no cure for SCAN1.</p><p>Supportive care is provided by specialists in neurology, rehabilitation medicine, occupational therapy, physical therapy, speech-language pathology, and clinical genetics.</p><p>Physical therapy may be helpful in maintaining a more active lifestyle.</p></div><div id="scan1.Surveillance"><h3>Surveillance</h3><p>Routine follow up as determined by treating specialists is recommended to monitor the response to supportive care and to assess for changes in existing manifestations and/or emergence of new manifestations.</p></div><div id="scan1.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Likely to be extremely harmful and possibly fatal:</p><ul><li class="half_rhythm"><div>Exposure to genotoxic anti-cancer drugs such as camptothecins (e.g., irinotecan and topotecan) and bleomycin [<a class="bibr" href="#scan1.REF.hirano.2007.4732" rid="scan1.REF.hirano.2007.4732">Hirano et al 2007</a>]</div></li><li class="half_rhythm"><div>Exposure to radiation [<a class="bibr" href="#scan1.REF.elkhamisy.2007.1485" rid="scan1.REF.elkhamisy.2007.1485">El-Khamisy et al 2007</a>]</div></li></ul></div><div id="scan1.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#scan1.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for genetic counseling purposes.</p></div><div id="scan1.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">ClinicalTrials.gov</a> in the US and <a href="https://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="scan1.Genetic_Counseling"><h2 id="_scan1_Genetic_Counseling_">Genetic Counseling</h2><p>
|
|
<i>Genetic counseling is the process of providing individuals and families with
|
|
information on the nature, mode(s) of inheritance, and implications of genetic disorders to help them
|
|
make informed medical and personal decisions. The following section deals with genetic
|
|
risk assessment and the use of family history and genetic testing to clarify genetic
|
|
status for family members; it is not meant to address all personal, cultural, or
|
|
ethical issues that may arise or to substitute for consultation with a genetics
|
|
professional</i>. —ED.</p><div id="scan1.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Spinocerebellar ataxia with axonal neuropathy type 1 (SCAN1) is inherited in an autosomal recessive manner.</p></div><div id="scan1.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p>
|
|
<b>Parents of a proband</b>
|
|
</p><ul><li class="half_rhythm"><div>The parents of an affected child are presumed to be heterozygous for a <i>TDP1</i> pathogenic variant.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a proband to confirm that both parents are heterozygous for a <i>TDP1</i> pathogenic variant and to allow reliable recurrence risk assessment.</div></li><li class="half_rhythm"><div>If a pathogenic variant is detected in only one parent and parental identity testing has confirmed biological maternity and paternity, it is possible that one of the pathogenic variants identified in the proband occurred as a <i>de novo</i> event in the proband or as a postzygotic <i>de novo</i> event in a mosaic parent [<a class="bibr" href="#scan1.REF.j_nsson.2017.519" rid="scan1.REF.j_nsson.2017.519">Jónsson et al 2017</a>]. If the proband appears to have homozygous pathogenic variants (i.e., the same two pathogenic variants), additional possibilities to consider include:</div><ul><li class="half_rhythm"><div>A single- or multiexon deletion in the proband that was not detected by sequence analysis and that resulted in the artifactual appearance of homozygosity;</div></li><li class="half_rhythm"><div>Uniparental isodisomy for the parental chromosome with the pathogenic variant that resulted in homozygosity for the pathogenic variant in the proband.</div></li></ul></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p>
|
|
<b>Sibs of a proband</b>
|
|
</p><ul><li class="half_rhythm"><div>If both parents are known to be heterozygous for a <i>TDP1</i> pathogenic variant, each sib of an affected individual has at conception a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of inheriting neither of the familial pathogenic variants.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p>
|
|
<b>Offspring of a proband</b>
|
|
</p><ul><li class="half_rhythm"><div>Unless an affected individual's reproductive partner also has SCAN1 or is a carrier, offspring will be obligate heterozygotes (carriers) for a <i>TDP1</i> pathogenic variant.</div></li><li class="half_rhythm"><div>The offspring of an individual with SCAN1 and an individual who is heterozygous for a <i>TDP1</i> pathogenic variant have a 50% chance of having SCAN1. This is a consideration in populations with a founder variant (see <a href="#scan1.Prevalence">Prevalence</a>) or with a high rate of consanguinity.</div></li></ul><p><b>Other family members of a proband.</b> Each sib of the proband's parents is at a 50% risk of being a carrier of a <i>TDP1</i> pathogenic variant.</p></div><div id="scan1.Carrier_Detection"><h3>Carrier Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>TDP1</i> pathogenic variants in the family.</p></div><div id="scan1.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>
|
|
<b>Family planning</b>
|
|
</p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal/preimplantation genetic testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or at risk of being carriers.</div></li><li class="half_rhythm"><div>Carrier testing for reproductive partners of known carriers should be considered, particularly if consanguinity is likely.</div></li></ul></div><div id="scan1.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p>Once the <i>TDP1</i> pathogenic variants have been identified in an affected family member, prenatal and preimplantation genetic testing for a pregnancy at increased risk are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing. While most centers would consider use of prenatal testing to be a personal decision, discussion of these issues may be helpful.</p></div></div><div id="scan1.Resources"><h2 id="_scan1_Resources_">Resources</h2><p>
|
|
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
|
|
support organizations and/or registries for the benefit of individuals with this disorder
|
|
and their families. GeneReviews is not responsible for the information provided by other
|
|
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/?report=reader">here</a>.</i></p>
|
|
<ul><li class="half_rhythm"><div>
|
|
<b>Ataxia UK</b>
|
|
</div><div>United Kingdom</div><div><b>Phone:</b> 0800 995 6037; +44 (0) 20 7582 1444 (from abroad)</div><div><b>Email:</b> help@ataxia.org.uk</div><div>
|
|
<a href="https://www.ataxia.org.uk" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">ataxia.org.uk</a>
|
|
</div></li><li class="half_rhythm"><div>
|
|
<b>euro-ATAXIA (European Federation of Hereditary Ataxias)</b>
|
|
</div><div>United Kingdom</div><div><b>Email:</b> ageorgousis@ataxia.org.uk</div><div>
|
|
<a href="https://www.euroataxia.org/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">euroataxia.org</a>
|
|
</div></li><li class="half_rhythm"><div>
|
|
<b>Hereditary Neuropathy Foundation</b>
|
|
</div><div><b>Phone:</b> 855-435-7268 (toll-free); 212-722-8396</div><div><b>Fax:</b> 917-591-2758</div><div><b>Email:</b> info@hnf-cure.org</div><div>
|
|
<a href="http://www.hnf-cure.org" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">www.hnf-cure.org</a>
|
|
</div></li><li class="half_rhythm"><div>
|
|
<b>National Ataxia Foundation</b>
|
|
</div><div><b>Phone:</b> 763-553-0020</div><div><b>Email:</b> naf@ataxia.org</div><div>
|
|
<a href="https://www.ataxia.org" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">ataxia.org</a>
|
|
</div></li><li class="half_rhythm"><div>
|
|
<b>CoRDS Registry</b>
|
|
</div><div>Sanford Research</div><div><b>Phone:</b> 605-312-6300</div><div>
|
|
<a href="https://research.sanfordhealth.org/rare-disease-registry" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">CoRDS Registry</a>
|
|
</div></li></ul>
|
|
</div><div id="scan1.Molecular_Genetics"><h2 id="_scan1_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. —</i>ED.</p><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figscan1molgenTA"><a href="/books/NBK1105/table/scan1.molgen.TA/?report=objectonly" target="object" title="Table A." class="img_link icnblk_img" rid-ob="figobscan1molgenTA"><img class="small-thumb" src="/corehtml/pmc/css/bookshelf/2.26/img/table-icon.gif" alt="Table Icon" /></a><div class="icnblk_cntnt"><h4 id="scan1.molgen.TA"><a href="/books/NBK1105/table/scan1.molgen.TA/?report=objectonly" target="object" rid-ob="figobscan1molgenTA">Table A.</a></h4><p class="float-caption no_bottom_margin">Spinocerebellar Ataxia with Axonal Neuropathy, Autosomal Recessive: Genes and Databases </p></div></div><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figscan1molgenTB"><a href="/books/NBK1105/table/scan1.molgen.TB/?report=objectonly" target="object" title="Table B." class="img_link icnblk_img" rid-ob="figobscan1molgenTB"><img class="small-thumb" src="/corehtml/pmc/css/bookshelf/2.26/img/table-icon.gif" alt="Table Icon" /></a><div class="icnblk_cntnt"><h4 id="scan1.molgen.TB"><a href="/books/NBK1105/table/scan1.molgen.TB/?report=objectonly" target="object" rid-ob="figobscan1molgenTB">Table B.</a></h4><p class="float-caption no_bottom_margin">OMIM Entries for Spinocerebellar Ataxia with Axonal Neuropathy, Autosomal Recessive (View All in OMIM) </p></div></div><div id="scan1.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><i>TDP1</i> encodes the nuclear protein tyrosyl-DNA phosphodiesterase 1 (TDP1), an enzyme that is a member of phospholipase D superfamily and participates in DNA damage repair by unblocking complexes of trapped topoisomerase 1 and DNA through cleavage of a diester bond. Phosphorylated TDP1 interacts with DNA ligase III alpha, a component of the single strand break repair machinery [<a class="bibr" href="#scan1.REF.elkhamisy.2005.108" rid="scan1.REF.elkhamisy.2005.108">El-Khamisy et al 2005</a>, <a class="bibr" href="#scan1.REF.das.2009.3667" rid="scan1.REF.das.2009.3667">Das et al 2009</a>, <a class="bibr" href="#scan1.REF.chiang.2010.588" rid="scan1.REF.chiang.2010.588">Chiang et al 2010</a>].</p><p>TDP1 contains two HKD motifs that comprise the active site of this enzyme and catalyze phosphoryl transfer reactions [<a class="bibr" href="#scan1.REF.interthal.2001.12009" rid="scan1.REF.interthal.2001.12009">Interthal et al 2001</a>].</p><p>Protein modeling showed that the pathogenic variant <a href="/books/NBK1105/table/scan1.T.notable_tdp1_pathogenic_variants/?report=objectonly" target="object" rid-ob="figobscan1Tnotabletdp1pathogenicvariants">p.His493Arg</a> disrupts the symmetric structure of the active center of the enzyme [<a class="bibr" href="#scan1.REF.takashima.2002.267" rid="scan1.REF.takashima.2002.267">Takashima et al 2002</a>]. The mutated TDP1 protein, which has decreased enzyme activity [<a class="bibr" href="#scan1.REF.elkhamisy.2005.108" rid="scan1.REF.elkhamisy.2005.108">El-Khamisy et al 2005</a>, <a class="bibr" href="#scan1.REF.interthal.2005b.2224" rid="scan1.REF.interthal.2005b.2224">Interthal et al 2005b</a>, <a class="bibr" href="#scan1.REF.zhou.2005.289" rid="scan1.REF.zhou.2005.289">Zhou et al 2005</a>, <a class="bibr" href="#scan1.REF.elkhamisy.2007.1260" rid="scan1.REF.elkhamisy.2007.1260">El-Khamisy & Caldecott 2007</a>], is also less efficient at repairing topo1-DNA complexes [<a class="bibr" href="#scan1.REF.interthal.2005b.2224" rid="scan1.REF.interthal.2005b.2224">Interthal et al 2005b</a>, <a class="bibr" href="#scan1.REF.miao.2006.1489" rid="scan1.REF.miao.2006.1489">Miao et al 2006</a>].</p><p>In the absence of wild type <i>TDP1</i> for DNA repair, the <a href="/books/NBK1105/table/scan1.T.notable_tdp1_pathogenic_variants/?report=objectonly" target="object" rid-ob="figobscan1Tnotabletdp1pathogenicvariants">p.His493Arg</a> TDP1 variant becomes covalently trapped in the normally transient TDP1-DNA intermediate state causing a DNA break [<a class="bibr" href="#scan1.REF.interthal.2005a.36518" rid="scan1.REF.interthal.2005a.36518">Interthal et al 2005a</a>, <a class="bibr" href="#scan1.REF.hirano.2007.4732" rid="scan1.REF.hirano.2007.4732">Hirano et al 2007</a>]. TDP1 also participates in maintenance of the mitochondrial genome and mitochondrial function. Mitochondrial dysfunction likely contributes to the pathophysiology of SCAN1 [<a class="bibr" href="#scan1.REF.fam.2018.4304" rid="scan1.REF.fam.2018.4304">Fam et al 2018</a>, <a class="bibr" href="#scan1.REF.huang.2019.3015" rid="scan1.REF.huang.2019.3015">Huang & Pommier 2019</a>]. Identification of additional disease-causing variants could improve understanding of the mechanism for disease causation.</p><p><b>Mechanism of disease causation.</b> Functional studies suggest a recessive neomorphic (gain-of-function) mechanism for the <a href="/books/NBK1105/table/scan1.T.notable_tdp1_pathogenic_variants/?report=objectonly" target="object" rid-ob="figobscan1Tnotabletdp1pathogenicvariants">c.1478A>G; p.His493Arg</a> variant.</p><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figscan1Tnotabletdp1pathogenicvariants"><a href="/books/NBK1105/table/scan1.T.notable_tdp1_pathogenic_variants/?report=objectonly" target="object" title="Table 3. " class="img_link icnblk_img" rid-ob="figobscan1Tnotabletdp1pathogenicvariants"><img class="small-thumb" src="/corehtml/pmc/css/bookshelf/2.26/img/table-icon.gif" alt="Table Icon" /></a><div class="icnblk_cntnt"><h4 id="scan1.T.notable_tdp1_pathogenic_variants"><a href="/books/NBK1105/table/scan1.T.notable_tdp1_pathogenic_variants/?report=objectonly" target="object" rid-ob="figobscan1Tnotabletdp1pathogenicvariants">Table 3. </a></h4><p class="float-caption no_bottom_margin">Notable <i>TDP1</i> Pathogenic Variants </p></div></div></div></div><div id="scan1.Chapter_Notes"><h2 id="_scan1_Chapter_Notes_">Chapter Notes</h2><div id="scan1.Author_History"><h3>Author History</h3><p>Cornelius Boerkoel, MD, PhD (2007-present)<br />Hok Khim Fam, BSc; University of British Columbia (2012-2022)<br />Ryuki Hirano, MD, PhD; Kagoshima University (2007-2012)<br />Mustafa AM Salih, MD, Dr Med Sci, FRCPCH (2007-present)<br />Hiroshi Takashima, MD, PhD (2007-present)</p></div><div id="scan1.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>30 June 2022 (bp) Comprehensive update posted live</div></li><li class="half_rhythm"><div>26 April 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 October 2007 (me) Review posted live</div></li><li class="half_rhythm"><div>26 September 2007 (cfb) Original submission</div></li></ul></div></div><div id="scan1.References"><h2 id="_scan1_References_">References</h2><div id="scan1.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.biesecker.2021.8">Biesecker
|
|
LG, Adam
|
|
MP, Alkuraya
|
|
FS, Amemiya
|
|
AR, Bamshad
|
|
MJ, Beck
|
|
AE, Bennett
|
|
JT, Bird
|
|
LM, Carey
|
|
JC, Chung
|
|
B, Clark
|
|
RD, Cox
|
|
TC, Curry
|
|
C, Dinulos
|
|
MBP, Dobyns
|
|
WB, Giampietro
|
|
PF, Girisha
|
|
KM, Glass
|
|
IA, Graham
|
|
JM
|
|
Jr, Gripp
|
|
KW, Haldeman-Englert
|
|
CR, Hall
|
|
BD, Innes
|
|
AM, Kalish
|
|
JM, Keppler-Noreuil
|
|
KM, Kosaki
|
|
K, Kozel
|
|
BA, Mirzaa
|
|
GM, Mulvihill
|
|
JJ, Nowaczyk
|
|
MJM, Pagon
|
|
RA, Retterer
|
|
K, Rope
|
|
AF, Sanchez-Lara
|
|
PA, Seaver
|
|
LH, Shieh
|
|
JT, Slavotinek
|
|
AM, Sobering
|
|
AK, Stevens
|
|
CA, Stevenson
|
|
DA, Tan
|
|
TY, Tan
|
|
WH, Tsai
|
|
AC, Weaver
|
|
DD, Williams
|
|
MS, Zackai
|
|
E, Zarate
|
|
YA. A dyadic approach to the delineation of diagnostic entities in clinical genomics.
|
|
Am J Hum Genet.
|
|
2021;108:8–15.
|
|
[<a href="/pmc/articles/PMC7820621/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC7820621</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33417889" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 33417889</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.chiang.2010.588">Chiang
|
|
SC, Carroll
|
|
J, El-Khamisy
|
|
SF. TDP1 serine 81 promotes interaction with DNA ligase IIIalpha and facilitates cell survival following DNA damage.
|
|
Cell Cycle.
|
|
2010;9:588–95.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/20009512" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 20009512</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.das.2009.3667">Das
|
|
BB, Antony
|
|
S, Gupta
|
|
S, Dexheimer
|
|
TS, Redon
|
|
CE, Garfield
|
|
S, Shiloh
|
|
Y, Pommier
|
|
Y. Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK.
|
|
EMBO J.
|
|
2009;28:3667–80.
|
|
[<a href="/pmc/articles/PMC2790489/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2790489</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19851285" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 19851285</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.elkhamisy.2007.1260">El-Khamisy
|
|
SF, Caldecott
|
|
KW. DNA single-strand break repair and spinocerebellar ataxia with axonal neuropathy-1.
|
|
Neuroscience.
|
|
2007;145:1260–6.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/17045754" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 17045754</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.elkhamisy.2007.1485">El-Khamisy
|
|
SF, Hartsuiker
|
|
E, Caldecott
|
|
KW. TDP1 facilitates repair of ionizing radiation-induced DNA single-strand breaks.
|
|
DNA Repair (Amst). 2007;6:1485–95.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/17600775" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 17600775</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.elkhamisy.2005.108">El-Khamisy
|
|
SF, Saifi
|
|
GM, Weinfeld
|
|
M, Johansson
|
|
F, Helleday
|
|
T, Lupski
|
|
JR, Caldecott
|
|
KW. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1.
|
|
Nature.
|
|
2005;434:108–13.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/15744309" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15744309</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.fam.2018.4304">Fam
|
|
HK, Choi
|
|
K, Fougner
|
|
L, Lim
|
|
CJ, Boerkoel
|
|
CF. Reactive oxygen species stress increases accumulation of tyrosyl-DNA phsosphodiesterase 1 within mitochondria.
|
|
Sci Rep.
|
|
2018;8:4304.
|
|
[<a href="/pmc/articles/PMC5844879/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5844879</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29523818" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29523818</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.hirano.2007.4732">Hirano
|
|
R, Interthal
|
|
H, Huang
|
|
C, Nakamura
|
|
T, Deguchi
|
|
K, Choi
|
|
K, Bhattacharjee
|
|
MB, Arimura
|
|
K, Umehara
|
|
F, Izumo
|
|
S, Northrop
|
|
JL, Salih
|
|
MA, Inoue
|
|
K, Armstrong
|
|
DL, Champoux
|
|
JJ, Takashima
|
|
H, Boerkoel
|
|
CF. Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation?
|
|
EMBO J.
|
|
2007;26:4732–43.
|
|
[<a href="/pmc/articles/PMC2080798/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2080798</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17948061" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 17948061</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.huang.2019.3015">Huang
|
|
SN, Pommier
|
|
Y. Mammalian tyrosyl-DNA phosphodiesterases in the context of mitochondrial DNA repair.
|
|
Int J Mol Sci.
|
|
2019;20:3015.
|
|
[<a href="/pmc/articles/PMC6628236/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6628236</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31226795" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31226795</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.interthal.2005a.36518">Interthal
|
|
H, Chen
|
|
HJ, Champoux
|
|
JJ. Human Tdp1 cleaves a broad spectrum of substrates, including phosphoamide linkages.
|
|
J Biol Chem.
|
|
2005a;280:36518–28.
|
|
[<a href="/pmc/articles/PMC1351008/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1351008</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16141202" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 16141202</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.interthal.2005b.2224">Interthal
|
|
H, Chen
|
|
HJ, Kehl-Fie
|
|
TE, Zotzmann
|
|
J, Leppard
|
|
JB, Champoux
|
|
JJ. SCAN1 mutant Tdp1 accumulates the enzyme--DNA intermediate and causes camptothecin hypersensitivity.
|
|
EMBO J.
|
|
2005b;24:2224–33.
|
|
[<a href="/pmc/articles/PMC1150888/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1150888</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15920477" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15920477</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.interthal.2001.12009">Interthal
|
|
H, Pouliot
|
|
JJ, Champoux
|
|
JJ. The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily.
|
|
Proc Natl Acad Sci U S A.
|
|
2001;98:12009–14.
|
|
[<a href="/pmc/articles/PMC59758/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC59758</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11572945" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11572945</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.j_nsson.2017.519">Jónsson
|
|
H, Sulem
|
|
P, Kehr
|
|
B, Kristmundsdottir
|
|
S, Zink
|
|
F, Hjartarson
|
|
E, Hardarson
|
|
MT, Hjorleifsson
|
|
KE, Eggertsson
|
|
HP, Gudjonsson
|
|
SA, Ward
|
|
LD, Arnadottir
|
|
GA, Helgason
|
|
EA, Helgason
|
|
H, Gylfason
|
|
A, Jonasdottir
|
|
A, Jonasdottir
|
|
A, Rafnar
|
|
T, Frigge
|
|
M, Stacey
|
|
SN, Th Magnusson
|
|
O, Thorsteinsdottir
|
|
U, Masson
|
|
G, Kong
|
|
A, Halldorsson
|
|
BV, Helgason
|
|
A, Gudbjartsson
|
|
DF, Stefansson
|
|
K. Parental influence on human germline de novo mutations in 1,548 trios from Iceland.
|
|
Nature.
|
|
2017;549:519–22.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/28959963" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28959963</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.miao.2006.1489">Miao
|
|
ZH, Agama
|
|
K, Sordet
|
|
O, Povirk
|
|
L, Kohn
|
|
KW, Pommier
|
|
Y. Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent topoisomerase I cleavage complexes.
|
|
DNA Repair (Amst). 2006;5:1489–94.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/16935573" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 16935573</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.richards.2015.405">Richards
|
|
S, Aziz
|
|
N, Bale
|
|
S, Bick
|
|
D, Das
|
|
S, Gastier-Foster
|
|
J, Grody
|
|
WW, Hegde
|
|
M, Lyon
|
|
E, Spector
|
|
E, Voelkerding
|
|
K, Rehm
|
|
HL; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
|
|
Genet Med.
|
|
2015;17:405-24.
|
|
[<a href="/pmc/articles/PMC4544753/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4544753</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25741868" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 25741868</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.scott.2019.139">Scott
|
|
P, Al Kindi
|
|
A, Al Fahdi
|
|
A, Al Yarubi
|
|
N, Bruwer
|
|
Z, Al Adawi
|
|
S, Nandhagopal
|
|
R. Spinocerebellar ataxia with axonal neuropathy type 1 revisited.
|
|
J Clin Neurosci.
|
|
2019;67:139–44.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/31182267" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31182267</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.stenson.2020.1197">Stenson
|
|
PD, Mort
|
|
M, Ball
|
|
EV, Chapman
|
|
M, Evans
|
|
K, Azevedo
|
|
L, Hayden
|
|
M, Heywood
|
|
S, Millar
|
|
DS, Phillips
|
|
AD, Cooper
|
|
DN. The Human Gene Mutation Database (HGMD®): optimizing its use in a clinical diagnostic or research setting.
|
|
Hum Genet.
|
|
2020;139:1197–207.
|
|
[<a href="/pmc/articles/PMC7497289/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC7497289</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32596782" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32596782</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.takashima.2002.267">Takashima
|
|
H, Boerkoel
|
|
CF, John
|
|
J, Saifi
|
|
GM, Salih
|
|
MA, Armstrong
|
|
D, Mao
|
|
Y, Quiocho
|
|
FA, Roa
|
|
BB, Nakagawa
|
|
M, Stockton
|
|
DW, Lupski
|
|
JR. Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy.
|
|
Nat Genet.
|
|
2002;32:267–72.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/12244316" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12244316</span></a>]</div></p></li><li class="half_rhythm"><p><div class="bk_ref" id="scan1.REF.zhou.2005.289">Zhou
|
|
T, Lee
|
|
JW, Tatavarthi
|
|
H, Lupski
|
|
JR, Valerie
|
|
K, Povirk
|
|
LF. Deficiency in 3'-phosphoglycolate processing in human cells with a hereditary mutation in tyrosyl-DNA phosphodiesterase (TDP1).
|
|
Nucleic Acids Res.
|
|
2005;33:289–97.
|
|
[<a href="/pmc/articles/PMC546157/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC546157</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15647511" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15647511</span></a>]</div></p></li></ul></div></div><div id="bk_toc_contnr"></div></div></div><div class="fm-sec"><h2 id="_NBK1105_pubdet_">Publication Details</h2><h3>Author Information and Affiliations</h3><div class="contrib half_rhythm"><span itemprop="author">Mustafa AM Salih</span>, MD, Dr Med Sci, FRCPCH<div class="affiliation small">Division of Pediatric Neurology<br />College of Medicine<br />King Saud University<br />Riyadh, Saudi Arabia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.oohay@50hilas_afatsum" class="oemail">moc.oohay@50hilas_afatsum</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Hiroshi Takashima</span>, MD, PhD<div class="affiliation small">Department of Neurology and Geriatrics<br />Kagoshima University Graduate School of Medical and Dental Sciences<br />Kagoshima, Japan<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.ca.u-amihsogak.mfuk.3m@ihsoriht" class="oemail">pj.ca.u-amihsogak.mfuk.3m@ihsoriht</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Cornelius F Boerkoel</span>, MD, PhD<div class="affiliation small">Provincial Medical Genetics Program<br />Child and Family Research Institute<br />Department of Medical Genetics<br />University of British Columbia<br />Vancouver, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.cbu.egnahcretni@leokreob" class="oemail">ac.cbu.egnahcretni@leokreob</a><span style="unicode-bidi: bidi-override; direction: ltr;">; </span><a href="mailto:dev@null" data-email="ac.cbu@leokreob.suilenroc" class="oemail">ac.cbu@leokreob.suilenroc</a><div></div></div></div></div><h3>Publication History</h3><p class="small">Initial Posting: <span itemprop="datePublished">October 22, 2007</span>; Last Update: <span itemprop="dateModified">June 30, 2022</span>.</p><h3>Copyright</h3><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2025, University of Washington, Seattle. GeneReviews is
|
|
a registered trademark of the University of Washington, Seattle. All rights
|
|
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
|
|
hereby granted to reproduce, distribute, and translate copies of content materials for
|
|
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&targetsite=external&targetcat=link&targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2025 University of
|
|
Washington) are included with each copy; (ii) a link to the original material is provided
|
|
whenever the material is published elsewhere on the Web; and (iii) reproducers,
|
|
distributors, and/or translators comply with the <a href="https://www.ncbi.nlm.nih.gov/books/n/gene/GRcopyright_permiss/" ref="pagearea=meta&targetsite=external&targetcat=link&targettype=uri">GeneReviews® Copyright Notice and Usage
|
|
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
|
|
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
|
|
use.</p><p class="small">For more information, see the <a href="https://www.ncbi.nlm.nih.gov/books/n/gene/GRcopyright_permiss/" ref="pagearea=meta&targetsite=external&targetcat=link&targettype=uri">GeneReviews® Copyright Notice and Usage
|
|
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
|
|
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div></div><h3>Publisher</h3><p><a href="http://www.washington.edu" ref="pagearea=page-banner&targetsite=external&targetcat=link&targettype=publisher">University of Washington, Seattle</a>, Seattle (WA)</p><h3>NLM Citation</h3><p>Salih MAM, Takashima H, Boerkoel CF. Spinocerebellar Ataxia with Axonal Neuropathy Type 1. 2007 Oct 22 [Updated 2022 Jun 30]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. <span class="bk_cite_avail"></span></p></div><div class="small-screen-prev"><a href="/books/n/gene/sca38/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="small-screen-next"><a href="/books/n/gene/spondylocostal-d/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></article><article data-type="table-wrap" id="figobscan1Tmoleculargenetictestingusedi"><div id="scan1.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Spinocerebellar Ataxia with Axonal Neuropathy Type 1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1105/table/scan1.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__scan1.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_scan1.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene <sup>1</sup></th><th id="hd_h_scan1.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_scan1.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants <sup>2</sup> Identified by Method</th></tr></thead><tbody><tr><td headers="hd_h_scan1.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>TDP1</i>
|
|
</td><td headers="hd_h_scan1.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis <sup>3</sup></td><td headers="hd_h_scan1.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">All variants reported to date <sup>4</sup></td></tr><tr><td headers="hd_h_scan1.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted deletion/duplication analysis <sup>5</sup></td><td headers="hd_h_scan1.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported to date <sup>4</sup></td></tr></tbody></table></div><div class="tblwrap-foot"><div><dl class="temp-labeled-list small"><dl class="bkr_refwrap"><dt>1. </dt><dd><div id="scan1.TF.1.1"><p class="no_margin">See <a href="/books/NBK1105/?report=reader#scan1.molgen.TA">Table A. Genes and Databases</a> for chromosome locus and protein.</p></div></dd></dl><dl class="bkr_refwrap"><dt>2. </dt><dd><div id="scan1.TF.1.2"><p class="no_margin">See <a href="#scan1.Molecular_Genetics">Molecular Genetics</a> for information on variants detected in this gene.</p></div></dd></dl><dl class="bkr_refwrap"><dt>3. </dt><dd><div id="scan1.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Variants may include missense, nonsense, and splice site variants and small intragenic deletions/insertions; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <a href="/books/n/gene/app2/?report=reader">here</a>.</p></div></dd></dl><dl class="bkr_refwrap"><dt>4. </dt><dd><div id="scan1.TF.1.4"><p class="no_margin"><a class="bibr" href="#scan1.REF.takashima.2002.267" rid="scan1.REF.takashima.2002.267">Takashima et al [2002]</a>, <a class="bibr" href="#scan1.REF.scott.2019.139" rid="scan1.REF.scott.2019.139">Scott et al [2019]</a>, and data derived from the subscription-based professional view of Human Gene Mutation Database [<a class="bibr" href="#scan1.REF.stenson.2020.1197" rid="scan1.REF.stenson.2020.1197">Stenson et al 2020</a>]</p></div></dd></dl><dl class="bkr_refwrap"><dt>5. </dt><dd><div id="scan1.TF.1.5"><p class="no_margin">Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods used may include a range of techniques such as quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p></div></dd></dl></dl></div></div></div></article><article data-type="table-wrap" id="figobscan1Tgenesofinterestinthediffere"><div id="scan1.T.genes_of_interest_in_the_differe" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Genes of Interest in the Differential Diagnosis of Spinocerebellar Ataxia with Axonal Neuropathy Type 1</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1105/table/scan1.T.genes_of_interest_in_the_differe/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__scan1.T.genes_of_interest_in_the_differe_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th></tr></thead><tbody><tr><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>ABHD12</i>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Polyneuropathy, hearing loss, ataxia, RP, & cataract (OMIM <a href="https://omim.org/entry/612674" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">612674</a>)</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pes cavus; Achilles tendon contractures; RP; ataxic &/or spastic gait; progressive sensorimotor peripheral neuropathy</td></tr><tr><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>APTX</i>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ataxia w/oculomotor apraxia type 1 (AOA1) (OMIM <a href="https://omim.org/entry/208920" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">208920</a>)</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early-onset cerebellar ataxia; axonal neuropathy; oculomotor apraxia; chorea or dystonia; ↓ serum concentration of albumin & ↑ total cholesterol. AOA1 can be distinguished from SCAN1 by presence of oculomotor apraxia (80% of persons w/AOA1), but this sign is not obvious in the early stages of disease.</td></tr><tr><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>ATM</i>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="/books/n/gene/ataxia-telangiectas/?report=reader">Ataxia-telangiectasia</a>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Telangiectasia; ataxia; cerebellar degeneration</td></tr><tr><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>COA7</i>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spinocerebellar ataxia w/axonal neuropathy 3 (OMIM <a href="https://omim.org/entry/618387" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">618387</a>)</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Childhood onset; axonal motor & sensory neuropathy; cerebellar ataxia cerebellum atrophy on MRI. Clinically similar to SCAN1.</td></tr><tr><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>CYP27A1</i>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="/books/n/gene/ctx/?report=reader">Cerebrotendinous xanthomatosis</a>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Symmetric distal sensory loss & weakness; cerebellar ataxia; upper motor signs; enlarged tendons</td></tr><tr><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>ERCC4</i>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ERCC4</i>-related <a href="/books/n/gene/xp/?report=reader">xeroderma pigmentosum</a></td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Freckle-like lesions, xerosis, & poikiloderma on sun-exposed skin; ocular abnormalities; in 25% of affected persons, progressive neurologic abnormalities</td></tr><tr><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>ERCC6</i>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ERCC6</i>-related <a href="/books/n/gene/cockayne/?report=reader">Cockayne syndrome</a></td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ID; demyelinating neuropathy; retinopathy; congenital cataracts; joint contractures; prominent nasal bridge; sensorineural hearing loss; severe motor dysfunction</td></tr><tr><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>FXN</i>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/friedreich/?report=reader">Friedreich ataxia</a> (FRDA)</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Slowly progressive ataxia; depressed tendon reflexes; dysarthria; muscle weakness; lower-limb spasticity; optic nerve atrophy; scoliosis; bladder dysfunction; loss of position & vibration senses; onset age usually <25 yrs</td></tr><tr><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>MRE11</i>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ataxia-telangiectasia-like disorder (OMIM <a href="https://omim.org/entry/604391" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">604391</a>)</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Similar to ataxia-telangiectasia; cerebellar degeneration; normal intellect</td></tr><tr><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>PHYH</i>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PHYH</i>-related <a href="/books/n/gene/refsum/?report=reader">Refsum disease</a></td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Childhood to adult onset; night blindness; demyelinating neuropathy; anosmia; ataxia; RP</td></tr><tr><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>PNKP</i>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ataxia w/oculomotor apraxia type 4 (OMIM <a href="https://omim.org/entry/616267" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">616267</a>)</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Childhood onset; dystonia; ataxia; oculomotor apraxia; cognitive impairment</td></tr><tr><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>POLG</i>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>POLG</i>-related ataxia neuropathy spectrum <sup>1</sup> (See <a href="/books/n/gene/alpers/?report=reader"><i>POLG</i>-Related Disorders</a>.)</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Adolescent to adult onset; sensory loss; ataxia; ophthalmoplegia</td></tr><tr><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>SACS</i>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="/books/n/gene/arsacs/?report=reader">ARSACS</a>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neuropathy; ataxia; spasticity; ID; prominent myelinated nerve fibers</td></tr><tr><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>SETX</i>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/aoa2/?report=reader">Ataxia w/oculomotor apraxia type 2</a> (AOA2)</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early-onset cerebellar ataxia; axonal neuropathy; oculomotor apraxia; chorea or dystonia; ↑ serum alpha-fetoprotein (AFP) level</td></tr><tr><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>SLC52A2</i>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC52A2</i>-related <a href="/books/n/gene/riboflavin-tn/?report=reader">riboflavin transporter deficiency</a></td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive bulbar palsy; childhood-onset sensorineural deafness; childhood-onset neuronopathy that is more prominent as upper than lower extremity weakness; tongue fasciculations & weakness; respiratory failure; optic atrophy; ↓ visual acuity</td></tr><tr><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<i>TTPA</i>
|
|
</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/aved/?report=reader">Ataxia w/vitamin E deficiency</a> (AVED)</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_scan1.T.genes_of_interest_in_the_differe_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cerebellar ataxia; loss of proprioception; areflexia; markedly ↓ plasma vitamin E (alpha-tocopherol) levels. AVED can be treated by vitamin E supplementation.</td></tr></tbody></table></div><div class="tblwrap-foot"><div><dl class="temp-labeled-list small"><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_margin">Adapted from <a class="bibr" href="#scan1.REF.scott.2019.139" rid="scan1.REF.scott.2019.139">Scott et al [2019]</a></p></div></dd></dl><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_margin">AR = autosomal recessive; ID = intellectual disability; MOI = mode of inheritance; RP = retinitis pigmentosa; SCAN1 = spinocerebellar ataxia with axonal neuropathy type 1</p></div></dd></dl><dl class="bkr_refwrap"><dt>1. </dt><dd><div id="scan1.TF.2.1"><p class="no_margin">The ataxia neuropathy spectrum (ANS) includes the phenotypes previously referred to as mitochondrial recessive ataxia syndrome (MIRAS) and sensory ataxia neuropathy dysarthria and ophthalmoplegia (SANDO).</p></div></dd></dl></dl></div></div></div></article><article data-type="table-wrap" id="figobscan1molgenTA"><div id="scan1.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Spinocerebellar Ataxia with Axonal Neuropathy, Autosomal Recessive: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1105/table/scan1.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__scan1.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_scan1.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_scan1.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_scan1.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_scan1.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_scan1.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_scan1.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_scan1.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">
|
|
<a href="/gene/55775" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=gene">
|
|
<i>TDP1</i>
|
|
</a>
|
|
</td><td headers="hd_b_scan1.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&acc=55775" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">14q32<wbr style="display:inline-block"></wbr>​.11</a>
|
|
</td><td headers="hd_b_scan1.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">
|
|
<a href="http://www.uniprot.org/uniprot/Q9NUW8" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Tyrosyl-DNA phosphodiesterase 1</a>
|
|
</td><td headers="hd_b_scan1.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">
|
|
<a href="http://databases.lovd.nl/shared/genes/TDP1" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">TDP1 database</a>
|
|
</td><td headers="hd_b_scan1.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">
|
|
<a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TDP1" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">TDP1</a>
|
|
</td><td headers="hd_b_scan1.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TDP1[gene]" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">TDP1</a>
|
|
</td></tr></tbody></table></div><div class="tblwrap-foot"><div><dl class="temp-labeled-list small"><dl class="bkr_refwrap"><dt></dt><dd><div id="scan1.TFA.1"><p class="no_margin">Data are compiled from the following standard references: gene from
|
|
<a href="http://www.genenames.org/index.html" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">HGNC</a>;
|
|
chromosome locus from
|
|
<a href="http://www.omim.org/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">OMIM</a>;
|
|
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">UniProt</a>.
|
|
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
|
|
<a href="/books/n/gene/app1/?report=reader">here</a>.</p></div></dd></dl></dl></div></div></div></article><article data-type="table-wrap" id="figobscan1molgenTB"><div id="scan1.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Spinocerebellar Ataxia with Axonal Neuropathy, Autosomal Recessive (<a href="/omim/607198,607250" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1105/table/scan1.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__scan1.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
|
<a href="/omim/607198" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=omim">607198</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TYROSYL-DNA PHOSPHODIESTERASE 1; TDP1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
|
<a href="/omim/607250" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=omim">607250</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1</td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobscan1Tnotabletdp1pathogenicvariants"><div id="scan1.T.notable_tdp1_pathogenic_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Notable <i>TDP1</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1105/table/scan1.T.notable_tdp1_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__scan1.T.notable_tdp1_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_scan1.T.notable_tdp1_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th><th id="hd_h_scan1.T.notable_tdp1_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide<br />Change</th><th id="hd_h_scan1.T.notable_tdp1_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted<br />Protein Change</th><th id="hd_h_scan1.T.notable_tdp1_pathogenic_variants_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment [Reference]</th></tr></thead><tbody><tr><td headers="hd_h_scan1.T.notable_tdp1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_018319.4" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_018319<wbr style="display:inline-block"></wbr>​.4</a>
|
|
<br />
|
|
<a href="https://www.ncbi.nlm.nih.gov/protein/NP_060789.2" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NP_060789<wbr style="display:inline-block"></wbr>​.2</a>
|
|
</td><td headers="hd_h_scan1.T.notable_tdp1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1478A>G</td><td headers="hd_h_scan1.T.notable_tdp1_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His493Arg</td><td headers="hd_h_scan1.T.notable_tdp1_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Founder variant reported in 2 apparently unrelated Omani families [<a class="bibr" href="#scan1.REF.scott.2019.139" rid="scan1.REF.scott.2019.139">Scott et al 2019</a>]; also reported in an unrelated Saudi Arabian family [<a class="bibr" href="#scan1.REF.takashima.2002.267" rid="scan1.REF.takashima.2002.267">Takashima et al 2002</a>]</td></tr></tbody></table></div><div class="tblwrap-foot"><div><dl class="temp-labeled-list small"><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd></dl><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="https://varnomen.hgvs.org/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/?report=reader">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></dl></div></div></div></article></div><div id="jr-scripts"><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/libs.min.js"> </script><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.min.js"> </script><script type="text/javascript">if (typeof (jQuery) != 'undefined') { (function ($) { $(function () { var min = Math.ceil(1); var max = Math.floor(100000); var randomNum = Math.floor(Math.random() * (max - min)) + min; var surveyUrl = "/projects/Gene/portal/surveys/seqdbui-survey.js?rando=" + randomNum.toString(); $.getScript(surveyUrl, function () { try { ncbi.seqDbUISurvey.init(); } catch (err) { console.info(err); } }).fail(function (jqxhr, settings, exception) { console.info('Cannot load survey script', jqxhr); });; }); })(jQuery); };</script></div></div>
|
|
|
|
|
|
|
|
|
|
<!-- Book content -->
|
|
|
|
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
|
|
|
|
|
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal106 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
|
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
|
|
|
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3968615.js" snapshot="books"></script></body>
|
|
</html>
|